NASDAQ:SSKN STRATA Skin Sciences (SSKN) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free SSKN Stock Alerts $0.51 -0.01 (-1.91%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.50▼$0.5350-Day Range$0.38▼$0.5652-Week Range$0.26▼$1.14Volume7,595 shsAverage Volume31,487 shsMarket Capitalization$18.04 millionP/E RatioN/ADividend YieldN/APrice Target$3.80 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get STRATA Skin Sciences alerts: Email Address STRATA Skin Sciences MarketRank™ Stock AnalysisAnalyst Rating0.00 Rating ScoreUpside/Downside638.6% Upside$3.80 Price TargetShort InterestHealthy0.86% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.56Based on 5 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.19) to ($0.10) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.25 out of 5 starsMedical Sector746th out of 913 stocksSurgical & Medical Instruments Industry81st out of 95 stocks 2.0 Analyst's Opinion Amount of Analyst CoverageSTRATA Skin Sciences has received no research coverage in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted0.86% of the float of STRATA Skin Sciences has been sold short.Short Interest Ratio / Days to CoverSTRATA Skin Sciences has a short interest ratio ("days to cover") of 6.Change versus previous monthShort interest in STRATA Skin Sciences has recently decreased by 26.95%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldSTRATA Skin Sciences does not currently pay a dividend.Dividend GrowthSTRATA Skin Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SSKN. Previous Next 2.5 News and Social Media Coverage News SentimentSTRATA Skin Sciences has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.32 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for STRATA Skin Sciences this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for SSKN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, STRATA Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders40.43% of the stock of STRATA Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.43% of the stock of STRATA Skin Sciences is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for STRATA Skin Sciences are expected to grow in the coming year, from ($0.19) to ($0.10) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STRATA Skin Sciences is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of STRATA Skin Sciences is -1.66, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSTRATA Skin Sciences has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About STRATA Skin Sciences Stock (NASDAQ:SSKN)STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.Read More SSKN Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SSKN Stock News HeadlinesApril 27, 2024 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces 1-for-10 Reverse Stock SplitApril 26, 2024 | marketwatch.comStrata Skin Sciences to Effect a 1-for-10 Reverse Stock SplitApril 27, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 26, 2024 | globenewswire.comSTRATA Skin Sciences Announces 1-for-10 Reverse Stock SplitApril 23, 2024 | globenewswire.comSTRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024April 23, 2024 | americanbankingnews.comSTRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52April 18, 2024 | msn.comSTRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11April 10, 2024 | msn.comSTRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in AsiaApril 27, 2024 | Colonial Metals (Ad)The Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.April 9, 2024 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanApril 9, 2024 | globenewswire.comSTRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanApril 1, 2024 | finance.yahoo.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call TranscriptMarch 31, 2024 | msn.comSTRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business ModelMarch 29, 2024 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsMarch 28, 2024 | benzinga.comEarnings Preview For Strata Skin SciencesMarch 28, 2024 | finance.yahoo.comQ4 2023 STRATA Skin Sciences Inc Earnings CallMarch 27, 2024 | benzinga.comRecap: Strata Skin Sciences Q4 EarningsMarch 27, 2024 | globenewswire.comSTRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsMarch 13, 2024 | globenewswire.comSTRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024March 11, 2024 | msn.comSpearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin TreatmentsMarch 7, 2024 | globenewswire.comSTRATA Skin Sciences Announces Initiative to Expand Treatment CoverageMarch 3, 2024 | seekingalpha.comSSKN STRATA Skin Sciences, Inc.February 29, 2024 | msn.comSTRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic InitiativesFebruary 27, 2024 | finanznachrichten.deSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialFebruary 26, 2024 | globenewswire.comSTRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialFebruary 22, 2024 | morningstar.comStrata Skin Sciences Inc SSKNJanuary 11, 2024 | finance.yahoo.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?See More Headlines Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2024Today4/26/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SSKN CUSIPN/A CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees99Year FoundedN/APrice Target and Rating Average Stock Price Target$3.80 High Stock Price Target$3.80 Low Stock Price Target$3.80 Potential Upside/Downside+638.6%Consensus Rating Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($0.31) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,830,000.00 Net Margins-32.47% Pretax Margin-32.74% Return on Equity-52.50% Return on Assets-17.66% Debt Debt-to-Equity Ratio1.19 Current Ratio1.28 Quick Ratio1.06 Sales & Book Value Annual Sales$33.36 million Price / Sales0.54 Cash FlowN/A Price / Cash FlowN/A Book Value$0.37 per share Price / Book1.39Miscellaneous Outstanding Shares35,060,000Free Float20,886,000Market Cap$18.04 million OptionableNot Optionable Beta1.58 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Christopher Lesovitz (Age 42)Chief Financial Officer Comp: $313.75kMr. Shmuel Gov (Age 64)Chief Operating Officer Comp: $470.52kDr. Dolev Rafaeli Ph.D. (Age 60)President, CEO & Vice-Chairman Comp: $282.72kMr. Jay Sturm (Age 68)General Counsel & Corporate Secretary Mr. Michael E. GoodmanHead of International SalesMr. Michael R. Stewart (Age 67)Independent Consultant Comp: $732.9kMore ExecutivesKey CompetitorsAkiliNASDAQ:AKLIMeihua International Medical TechnologiesNASDAQ:MHUAPAVmedNASDAQ:PAVMGlucoTrackNASDAQ:GCTKPolyPidNASDAQ:PYPDView All CompetitorsInsiders & InstitutionsAzzad Asset Management Inc. ADVBought 49,800 shares on 4/19/2024Ownership: 0.191%Chicago Partners Investment Group LLCBought 39,706 shares on 2/23/2024Ownership: 0.183%Cannell Capital LLCSold 75,805 shares on 2/15/2024Ownership: 0.787%Shmuel GovBought 20,000 shares on 12/1/2023Total: $9,000.00 ($0.45/share)Samuel RubinsteinSold 1,000 sharesTotal: $320.00 ($0.32/share)View All Insider TransactionsView All Institutional Transactions SSKN Stock Analysis - Frequently Asked Questions What is STRATA Skin Sciences' stock price target for 2024? 0 Wall Street research analysts have issued 12-month price targets for STRATA Skin Sciences' shares. Their SSKN share price targets range from $3.80 to $3.80. On average, they anticipate the company's stock price to reach $3.80 in the next year. This suggests a possible upside of 638.6% from the stock's current price. View analysts price targets for SSKN or view top-rated stocks among Wall Street analysts. How have SSKN shares performed in 2024? STRATA Skin Sciences' stock was trading at $0.5501 at the beginning of 2024. Since then, SSKN shares have decreased by 6.5% and is now trading at $0.5145. View the best growth stocks for 2024 here. Are investors shorting STRATA Skin Sciences? STRATA Skin Sciences saw a decline in short interest in April. As of April 15th, there was short interest totaling 157,200 shares, a decline of 27.0% from the March 31st total of 215,200 shares. Based on an average daily trading volume, of 26,000 shares, the short-interest ratio is currently 6.0 days. Approximately 0.9% of the company's stock are short sold. View STRATA Skin Sciences' Short Interest. When is STRATA Skin Sciences' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our SSKN earnings forecast. How were STRATA Skin Sciences' earnings last quarter? STRATA Skin Sciences, Inc. (NASDAQ:SSKN) announced its quarterly earnings results on Wednesday, March, 27th. The medical device company reported ($0.04) earnings per share for the quarter. The medical device company earned $8.69 million during the quarter. STRATA Skin Sciences had a negative trailing twelve-month return on equity of 52.50% and a negative net margin of 32.47%. When did STRATA Skin Sciences' stock split? Shares of STRATA Skin Sciences reverse split on the morning of Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. What other stocks do shareholders of STRATA Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include Trevena (TRVN), Amarin (AMRN), Biocept (BIOC), Kopin (KOPN), OPKO Health (OPK), Plug Power (PLUG), AbbVie (ABBV), SCYNEXIS (SCYX), Tonix Pharmaceuticals (TNXP) and Agile Therapeutics (AGRX). Who are STRATA Skin Sciences' major shareholders? STRATA Skin Sciences' stock is owned by a number of retail and institutional investors. Top institutional investors include Azzad Asset Management Inc. ADV (0.19%). Insiders that own company stock include Christopher Lesovitz, Robert Joseph Moccia, Samuel Rubinstein, Shmuel Gov and William D Humphries. View institutional ownership trends. How do I buy shares of STRATA Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SSKN) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STRATA Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
